Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies.

Ayan, Gizem; Esatoglu, Sinem Nihal; Hatemi, Gulen; Ugurlu, Serdal; Seyahi, Emire; Melikoglu, Melike; Fresko, Izzet; Ozdogan, Huri; Yurdakul, Sebahattin; Hamuryudan, Vedat

Ayan, Gizem; Esatoglu, Sinem Nihal; Hatemi, Gulen; Ugurlu, Serdal; Seyahi, Emire; Melikoglu, Melike; Fresko, Izzet; Ozdogan, Huri; Yurdakul, Sebahattin; Hamuryudan, Vedat.

Afiliação

Ayan G; Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey.
Esatoglu SN; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
Hatemi G; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
Ugurlu S; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
Seyahi E; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
Melikoglu M; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
Fresko I; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
Ozdogan H; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
Yurdakul S; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey.
Hamuryudan V; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Cerrahpasa Medical School, Istanbul University, Fatih, Istanbul, Turkey. vhamuryudan@yahoo.com.

Rheumatol Int ; 38(4): 607-622, 2018 Apr.

Article em En | MEDLINE | ID: mdl-29322343

Assuntos

Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/tratamento farmacológico; Fatores Imunológicos/uso terapêutico; Rituximab/uso terapêutico; Adulto; Idoso; Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/sangue; Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/imunologia; Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/mortalidade; Anticorpos Anticitoplasma de Neutrófilos/sangue; Biomarcadores/sangue; Feminino; Humanos; Fatores Imunológicos/efeitos adversos; Masculino; Pessoa de Meia-Idade; Indução de Remissão; Estudos Retrospectivos; Rituximab/efeitos adversos; Fatores de Tempo; Resultado do Tratamento; Adulto Jovem

Palavras-chave

ANCA-vasculitis; Granulomatosis with polyangiitis; Rituximab; Systemic vasculitis; Treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos / Rituximab / Fatores Imunológicos Tipo de estudo: Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatol Int Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Turquia País de publicação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google